LEGN Reports $555M Q4 CARVYKTI Sales, $1.9B FY Sales, 10K Patients Treated, $949M Cash, Profitable 2025
Legend Biotech Corporation American Depositary Shares · Now $25.51
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS